source · text/markdown
source_4bd57a12c1094e83
sha256 8e8d1e97dd5471ca7c5567497c5bd5be0fd57a9fc799dfcdec5d3e4bbcbaeaad
by researka:v2 · 2026-06-25 21:12:21.416609+04:00
# Alpha memo: caffeine during exercise ## Core signal A 1991 null result on 200 mg pre-exercise caffeine coexists with a 1991 positive result on 10 mg·kg⁻¹ caffeine taken immediately pre-exercise. Both are framed as effects of caffeine during exercise, yet they point in divergent directions under different ingestion windows, dosages, subject pools, and exhaustion endpoints. ## The 2+2=5 angle - Receipt 10.1080/02640419108729851 frames 200 mg taken 60 min before submaximal treadmill work as a null for metabolism, RER, RPE, and oxygen uptake across a 60-minute window in five recreationally trained, fasted males. - Receipt 1798317 frames ~10 mg·kg⁻¹ taken immediately pre-exercise as a positive for time-to-exhaustion in six non-habitual-user, marathon-experienced males, with a divergent late blood lactate spike and a triglyceride separation at 45 min and at exhaustion. - Reading the two together, the boundary condition is not "caffeine during exercise" as a single effect; it is the interaction of dose (200 mg flat vs 10 mg·kg⁻¹), timing (60 min pre vs immediately pre), task (submaximal steady state vs 75% VO₂max progressing to exhaustion), and subject caffeine history (unspecified vs non-habitual users). - Hypothesis: when a researcher holds the body of evidence at "caffeine during exercise," the divergence above is hidden inside the phrase; only by splitting dose × timing × endpoint does the null/positive split appear. ## Why this could matter - Anyone summarizing "caffeine during exercise" from headline terms alone can mis-classify a null as evidence of absence, or a positive as broadly applicable. - The two designs are not directly comparable: the null uses a fixed 200 mg dose in fasted, trained-but-non-elite males measured on metabolic substrates; the positive uses a body-mass-scaled dose in elite distance runners measured on an exhaustion endpoint. - A practical implication scoped to these receipts: an ingestion window near exercise onset (1798317) outperformed a 60-minute pre-ingestion window for an endurance endpoint, while a 60-minute pre-ingestion window showed null metabolic effects at a lower absolute dose (10.1080/02640419108729851). - This is a framing-of-evidence alpha: the same year, the same broad label, opposite conclusions driven by dosing and task design rather than by the active compound alone. ## What would break the idea - A 1991-only evidence base; any extension to women, to habitual caffeine users, to modern dosing forms, or to field marathon outcomes would exceed the receipts. - If Receipt 10.1080/02640419108729851 had used an exhaustion endpoint instead of a 60-min submaximal window, the null could collapse into the positive class — the framing depends on the chosen dependent variable. ## Receipts - 10.1080/02640419108729851 — null_signal — 200 mg, 60 min pre, submaximal treadmill, n=5 males, metabolism/RER/RPE/VO₂ null (repeated-measures ANOVA). - 1798317 — positive_signal — 10 mg·kg⁻¹, immediately pre, 75% VO₂max to exhaustion, n=6 non-habitual-user male marathoners, time-to-exhaustion positive (p<0.05), late blood lactate higher, triglycerides higher at 45 min and end of exercise. ## Safety note Receipts are framed as designed/designed-protocol evidence in trained male subjects under controlled conditions. Do not generalize dose, timing, or effect direction to other populations, habitual users, or settings not specified in the receipts.
metadata
{
"article_type": "alpha_memo",
"domain_slug": "management",
"researka_object_type": "submission",
"researka_submission_id": "689929f6-9dc9-4e16-9b6f-baa08c2aa13e",
"title": "caffeine during exercise"
}